Clinical Trials Logo

Clinical Trial Summary

This non-interventional, observational study evaluates the efficacy of Targinact with regard to quality of life in daily clinical practice in Belgium compared to the previous analgesic treatment.


Clinical Trial Description

Patients are treated with Targinact® according to daily clinical practice during at least 12 weeks and are monitored during study 3 visits. Parameters assessed are overall health assessment of the patient, pain relief, constipation, use of laxatives, use of analgesic rescue medication, use of concomitant medication, quality of life and safety of Targinact® treatment. These parameters, except for safety assessment, are compared between Targinact® treatment and previous analgesic treatment. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01710917
Study type Observational
Source Mundipharma CVA
Contact Maggie C Wilson
Email Info@contact-clinical-trials.com
Status Recruiting
Phase Phase 4
Start date September 2012
Completion date January 2014

See also
  Status Clinical Trial Phase
Completed NCT01710904 - A Non-interventional, Observational Study for Targinact® Treatment in Patients With Chronic Severe Pain N/A